ArticleNature biomedical engineering2020

Validation of the use of a fluorescent PARP1 inhibitor for the detection of oral, oropharyngeal and oesophageal epithelial cancers.

Susanne Kossatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.